⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLYB News
Rallybio Corporation Common Stock
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
businesswire.com
RLYB
Rallybio Announces Reverse Stock Split of Common Stock
businesswire.com
RLYB
Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates
businesswire.com
RLYB
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
businesswire.com
RLYB
RLYB